It is a healthcare private limited company based in Delhi, Delhi, India, established in 2013.
2013 | Delhi, Delhi, India | ActiveSonrisa Pharmaceuticals Private Limited, a active private limited company, was established on 01 March 2013 in Delhi, Delhi, India. Engaging in other hospital and medical care activities within the hospital and medical care sector, it holds CIN: U33100DL2013PTC248922. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Mukesh Thakur Kumar (Director), Deepak Kumar (Director). Past directors included Rita Thakur, Ritesh Kumar Thakur, Saurabh Dhingra. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Unit No.- 112, Rg Bazar, Cs/Ocf No.-8, Sector-11, Extension Rohini, Delhi, Delhi, 110085.
U33100DL2013PTC248922
248922
01 March 2013
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Sonrisa Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mukesh Thakur Kumar | Director | 12 Apr 2019 | Current |
| Deepak Kumar | Director | 17 Sep 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Apr 2019 | Past |
| Pramod Abcsdd | Director | 17 Sep 2022 | Past |
| Pramod Abcsdd | Director | 07 Dec 2014 | Past |
| Pramod Abcsdd | Director | 27 Jul 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sonrisa Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 74.63% decrease in profit. The company's net worth dipped by a decrease of 2.93%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Sonrisa Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sonrisa Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sonrisa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sonrisa Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sonrisa Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
Progress on Sonrisa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi. was documented.
The activity Deepak Kumar was appointed as a Director was appointed as a Director on 17 Sep 2022 & has been associated with this company since 3 years 3 months . was completed.
The activity Mukesh Thakur Kumar was appointed as a Director was appointed as a Director on 12 Apr 2019 & has been associated with this company since 6 years 8 months . was completed.
Sonrisa Pharmaceuticals Private Limited was registered on 01 Mar 2013 with Roc Delhi & aged 12 years 9 months as per MCA records. was recorded as a recent event.
The CIN of Sonrisa Pharmaceuticals Private Limited is U33100DL2013PTC248922.
Sonrisa Pharmaceuticals Private Limited is headquartered at Unit No.- 112, Rg Bazar, Cs/Ocf No.-8, Sector-11, Extension Rohini, Delhi, Delhi, 110085.
Sonrisa Pharmaceuticals Private Limited was incorporated on 01 March 2013.
The current directors of Sonrisa Pharmaceuticals Private Limited are
The primary industry of Sonrisa Pharmaceuticals Private Limited is Hospital And Medical Care.
Sonrisa Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sonrisa Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Sonrisa Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX